Skip to main content
NIH funding notice RFA-HD-21-026

Maternal and Pediatrics Precision in Therapeutics Hub (MPRINT) (P50 Clinical Trial Optional)

Closed on November 30, 2020.

Posted
August 3, 2020
Close date
November 30, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,500,000 in first-year total cost, median $1,250,000.

Most frequent study sections

  1. Special Emphasis Panel[ZHD1 DSR-R (58)]2

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA, SAN DIEGO1
  2. VANDERBILT UNIVERSITY MEDICAL CENTER1
Competing awards under RFA-HD-21-026 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2021Vanderbilt Integrated Center of Excellence in Maternal and Pediatric Precision Therapeutics (VICE-MPRINT)1P50HD106446-01KANNANKERIL, PRINCE JOSEPHVAN DRIEST, SARA LYNNVANDERBILT UNIVERSITY MEDICAL CENTER, TN$1,250,000ZHD1
2021Optimization of Antibiotics in Mothers and their Breastfed Infants Using Pharmacomicrobiomic and Metabolomic Analyses1P50HD106463-01BODE, LARSCHAMBERS, CHRISTINANIZET, VICTORTREMOULET, ADRIANA HTSUNODA, SHIRLEY MUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$1,250,000ZHD1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.